• 1
    Starzl TE, Ishikawa M, Putnam CW, Porter KA, Picache R, Husberg BS, et al. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transpl Proc 1974; 6: 129-139.
  • 2
    Moore SB, Wiesner RH, Perkins JD, Nagorney DM, Sterioff S, Krom RA. A positive lymphocyte cross-match and major histocompatibility complex mismatching do not predict early rejection of liver transplants in patients treated with cyclosporine. Transpl Proc 1987; 19: 2390-2391.
  • 3
    Shiraishi M, Csete ME, Yasunaga C, Drazan KE, Jurim O, Cramer DV, et al. Regeneration-induced accelerated rejection in reduced-size liver grafts. Transplantation 1994; 57: 336-340.
  • 4
    Omura T, Nakagawa T, Randall HB, Lin Z, Huey M, Ascher NL, Emond JC. Increased immune responses to regenerating partial liver grafts in the rat. J Surg Res 1997; 70: 34-40.
  • 5
    Astarcioglu I, Cursio R, Reynes M, Gugenheim J. Increased risk of antibody-mediated rejection of reduced-size liver allografts. J Surg Res 1999; 87: 258-262.
  • 6
    Francavilla R, Hadzic N, Underhill J, Heaton N, Rela M, Mieli VG, Donaldson P. Role of HLA compatibility in pediatric liver transplantation. Transplantation 1998; 66: 53-58.
  • 7
    Rodey GE, Fuller TC. Public epitopes and the antigenic structure of the HLA molecules. Crit Rev Immunol 1987; 7: 229-267.
  • 8
    Rodey GE, Neylan JF, Whelchel JD, Revels KW, Bray RA. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994; 39: 272-280.
  • 9
    Takemoto S, Gjertson DW, Terasaki PI. HLA matching: a comparison of conventional and molecular approaches. In: TerasakiPI, CeckaM, eds. Clinical Transplants 1992. Los Angeles: UCLA Tissue Typing Laboratory, 1992: 413-434.
  • 10
    Thompson JS, Thacker LR. CREG matching for first cadaveric kidney transplants (TNX) performed by SEOPF centers between October 1987 and September 1995. Southeastern Organ Procurement Foundation. Clin Transpl 1996; 10: 586-593.
  • 11
    Thompson JS, Thacker LR, Takemoto S. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry. Transplantation 2000; 69: 2178-2186.
  • 12
    Peeters PM, Sieders E, van den Heuvel M, Bijleveld CM, de Jong KP, TenVergert EM, et al. Predictive factors for portal fibrosis in pediatric liver transplant recipients. Transplantation 2000; 70: 1581-1587.
  • 13
    Ray JG. NIH lymphocyte microcytotoxicity technique. NIAID Manual of Tissue Typing Techniques (DHEW Publication (NIH) 77-545). Washington: Department of Health, Education, and Welfare, 1977.
  • 14
    van Rood JJ, van Leeuwen A, Ploem JS. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature 1976; 262: 795-797.
  • 15
    Schreuder GM, Hurley CK, Marsh SGE, Lau M, Maiers M, Kollman C, Noreen H. The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens 1999; 54: 409-437.
  • 16
    Demetris AJ, Batts KP, Dhillon AP. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-663.
  • 17
    Demetris AJ, Seaberg EC, Batts KP, Ferrell LD, Ludwig J, Markin RS, et al. Reliability and predictive value of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database nomenclature and grading system for cellular rejection of liver allografts. Hepatology 1995; 21: 408-416.
  • 18
    Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-1417.
  • 19
    Doran TJ, Geczy AF, Painter D, McCaughan G, Sheil AG, Susal C, Opelz G. A large, single center investigation of the immunogenetic factors affecting liver transplantation. Transplantation 2000; 69: 1491-1498.
  • 20
    Neumann UP, Guckelberger O, Langrehr JM, Lang M, Schmitz V, Theruvath T, et al. Impact of human leucocyte antigen matching in liver transplantation. Transplantation 2003; 75: 132-137.
  • 21
    Donaldson PT. Immunogenetics in liver disease. In: MannsMP, ed. Gastroenterology and Liver Immunology. London: Bailliere Tindall, 1996: 533.
  • 22
    Sugawara Y, Mizuta K, Kawarasaki H, Takayama T, Imamura H, Makuuchi M. Risk related factors for acute rejection in pediatric living related liver transplantation: the impact of HLA matching. Liver Transpl 2001; 7: 769-773.
  • 23
    Kasahara M, Kiuchi T, Uryuhara K, Uemoto S, Fujimoto Y, Ogura Y, et al. Role of HLA compatibility in pediatric living-related liver transplantation. Transplantation 2002; 74: 1175-1180.
  • 24
    Markus BH, Duquesnoy RJ, Gordon RD, Fung JJ, Vanek M, Klintmalm G, et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988; 46: 372-377.
  • 25
    Taub R. Liver regeneration in health and disease. Clin Lab Med 1996; 16: 341-360.
  • 26
    Ho M. Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus. Infect Immun 1980; 27: 767-776.
  • 27
    Manez R, White LT, Linden P, Kusne S, Martin M, Kramer D, et al. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Transplantation 1993; 55: 1067-1071.
  • 28
    O'Grady JG, Alexander GJ, Sutherland S, Donaldson PT, Harvey F, Portmann B, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 1988; 2: 302-305.